STRS Ohio’s Adaptive Biotechnologies ADPT Stock Holding History

STRS Ohio’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Sell	53,200 -2,700	-5%	-$41.4K	﹤0.01%	681
2026 Q1	$776K	Hold	55,900	–	–	﹤0.01%	803
2025 Q4	$908K	Sell	55,900 -10,000	-15%	-$163K	﹤0.01%	736
2025 Q3	$986K	Sell	65,900 -5,900	-8%	-$71.9K	﹤0.01%	690
2025 Q2	$836K	Sell	71,800 -10,500	-13%	-$95.4K	﹤0.01%	986
2025 Q1	$611K	Sell	82,300 -9,400	-10%	-$72.2K	﹤0.01%	1061
2024 Q4	$550K	Hold	91,700	–	–	﹤0.01%	1142
2024 Q3	$470K	Hold	91,700	–	–	﹤0.01%	1289
2024 Q2	$332K	Buy	91,700 +9,400	+11%	+$29.8K	﹤0.01%	1405
2024 Q1	$264K	Sell	82,300 -5,200	-6%	-$20.1K	﹤0.01%	1478
2023 Q4	$428K	Buy	87,500 +3,800	+5%	+$17.3K	﹤0.01%	1339
2023 Q3	$456K	Hold	83,700	–	–	﹤0.01%	1312
2023 Q2	$561K	Buy	83,700 +2,700	+3%	+$20.1K	﹤0.01%	1214
2023 Q1	$715K	Hold	81,000	–	–	﹤0.01%	1086
2022 Q4	$618K	Sell	81,000 -15,500	-16%	-$121K	﹤0.01%	1190
2022 Q3	$687K	Buy	96,500 +2,600	+3%	+$24.5K	﹤0.01%	1125
2022 Q2	$759K	Buy	+93,900	New	+$826K	﹤0.01%	1086
2021 Q2	–	Sell	-22,380	Closed	-$901K	–	2224
2021 Q1	$901K	Buy	22,380 +7,361	+49%	+$398K	﹤0.01%	1227
2020 Q4	$888K	Sell	15,019 -3,429	-19%	-$177K	﹤0.01%	1139
2020 Q3	$897K	Buy	18,448 +5,375	+41%	+$226K	﹤0.01%	981
2020 Q2	$632K	Buy	+13,073	New	+$477K	﹤0.01%	1137

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

STRS Ohio's ADPT Position: Q2 2026 in Review

STRS Ohio reduced its Adaptive Biotechnologies (ADPT) stake by 4.8% in Q2 2026, selling an estimated $41.4K and leaving 53,200 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #681.

STRS Ohio first reported a position in ADPT in Q2 2020 and has held it in 21 quarters since. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

STRS Ohio held 53,200 shares of Adaptive Biotechnologies worth $1.14M as of Q2 2026.
STRS Ohio sold 2,700 Adaptive Biotechnologies shares in Q2 2026, an estimated $41.4K.
Adaptive Biotechnologies made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #681 holding.
STRS Ohio first reported a position in Adaptive Biotechnologies in Q2 2020 and has held it in 21 quarters since.
301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.